• Shashi

Cell and gene therapies for cancer: Future promises and challenges

Updated: Apr 7, 2019



Webinar on Cell and Gene Therapies for Cancer

This is the subject of a 60-min webinar on 23rd January 2019.


There has been an "explosion” of interest in this area largely due to the success of chimeric antigen receptor (CAR) T-cell therapy. The fields of immunology and gene therapy have converged to harness recombinant viruses to deliver “living drugs” with remarkable clinical efficacy, especially for patients with blood cancers. Multiple approaches to engineer immune cells—mostly T cells but also other immune cell types—make use of CARs, while tumor-specific T-cell receptors continue to gain a foothold in the field, mostly for the treatment of solid tumors


During the webinar, the speakers will:

Outline the current state of cell therapy and gene therapy for #cancer

Share their experience with the challenges of applying these therapies in a practical way

Speculate on possible future directions and applications for cell and gene therapy, including adoptive immunotherapy safety and efficacy, and advances in T-cell bioengineering methodologies

#celltherapy #genetherapy


More details and registration available through this site: https://www.sciencemag.org/custom-publishing/webinars/cell-and-gene-therapies-cancer-future-promises-and-challenges


13 views

Recent Posts

See All

Chronic heart failure is the most common reason for hospital admissions and one of the most frequent causes of death in the western world. Scientists around the world are therefore working on strategi

"Autoimmune diseases, chronic in nature, are generally hard to alleviate. Present long-term treatments with available drugs such as steroids, immune-suppressive drugs, or antibodies have several debil